HIV sero-positivity in recently admitted and long-term psychiatric in-patients: Prevalence and diagnostic profile

African Journal of Psychiatry (South Africa)

Volumn 15, Issue 1, 2012, Pages 47-53

  Henning, M P ^a   Kruger C ^a   Fletcher, L ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Diagnostic profile; HIV sero positivity; Prevalence; Psychiatric patients

Indexed keywords

CANNABIS;

ADULT; ARTICLE; BIPOLAR DISORDER; CHRONIC PATIENT; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; GENDER; HIGH RISK BEHAVIOR; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMAN IMMUNODEFICIENCY VIRUS RAPID SCREENING TEST; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ABUSE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DEFICIENCY; MENTAL PATIENT; PERSONALITY DISORDER; RECENT ADMISSION; SCHIZOAFFECTIVE PSYCHOSIS; SCREENING TEST; SELF REPORT; SENSITIVITY AND SPECIFICITY; SEX RATIO; SEXUAL BEHAVIOR; SUBSTANCE ABUSE; SYPHILIS;

ADULT; COMORBIDITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV SEROPOSITIVITY; HUMANS; INPATIENTS; MALE; MENTAL DISORDERS; PREVALENCE; RISK-TAKING; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; SEXUAL BEHAVIOR; SOUTH AFRICA; SUBSTANCE ABUSE, INTRAVENOUS; SYPHILIS; TIME;

EID: 84857867534     PISSN: 19948220     EISSN: None     Source Type: Journal    
DOI: 10.4314/ajpsy.v15i1.7     Document Type: Article

References (25)

1. Owe-Larsson B, Sall L, Salamon E, Allgulander C. HIV infection and psychiatric illness. Afr J Psychiatry 2009; 12(2), 115-28.
2. Angelino AF, Treisman GJ. Issues in co-morbid severe mental illnesses in HIV infected individuals. Int Rev Psychiatry 2008; 20(1), 95-101.
3. Meade CS, Sikkema KJ. HIV risk behavior among adults with severe mental illness: a systematic review. Clin Psychiatry Rev 2005; 25, 433-57.
4. South Africa. Department of Health. National HIV Counselling and Testing Policy Guidelines. Pretoria: Department of Health; 2010.
5. Van Wyk S, Von Brandis-Martini P, Pretorius HW, Webber LM. HIV seroprevalence and associated factors in two hundred acute psychiatric admission. S Afr J Epidemiol Infect 2004; 19(2), 63-8.
6. Singh D, Berkman A, Bresnahan M. Seroprevalence and HIVassociated factors among adults with severe mental illness - a vulnerable population. S Afr Med J 2009; 99, 523-7.
7. Blank MB, Mandell DS, Aiken L, Hadley TR. Co-occurrence of HIV and serious mental illness among Medicaid recipients. Psychiatr Serv 2002; 53(7), 868-73.
8. Karp G, Schlaeffer, Jotkowitz A, Riesenberg K. Syphilis and HIV co-infection. Eur J Intern Med 2009; 20(1), 9-13.
9. Zetola NM, Engelman J, Jensen TP, Klausner JD. Syphilis in the United States: an update for clinicians with an emphasis on HIV coinfection. Mayo Clin Proc 2007; 82(9), 1091-102.
10. Jin F, Prestage G, Zablotska I, Rawstorne P, Imrie J, Kippax S, et al. High incidence of syphilis in HIV-positive homosexual men: data from two community-based cohort studies. Sex Health 2009; 6(4), 281-4.
11. Lynn WA, Lightman S. Syphilis and HIV: a dangerous combination. Lancet Infect Dis 2004; 4(7), 456-66.
12. Kent E, Romanelli F. Re-examining syphilis: an update on epidemiology, clinical manifestations, and management. Ann Pharmacother 2008; 42(2), 226-36.
13. Marra CM, Maxwell CL, Smith SL, Lukehart SA, Rompalo AM, Eaton M, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004; 189(3), 369-76.
14. French P. Syphilis - clinical review. BMJ 2007; 334, 143-7.
15. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines; recommendations and reports; no RR-11. [report on the Internet]. MMWR Morb Mortal Wkly Rep 2006; 55, 1-100. Available from: http://www.cdc.gov/std/treatment/2006/rr5511.pdf.
16. World Health Organization. Guidelines for the implementation of reliable and efficient diagnostic HIV testing: region of the Americas. Technical series on HIV comprehensive care with public health approach (CC-VIH). Washington DC: Pan American Health Organization; 2008.
17. ACON Laboratories. Tri-line HIV rapid test device; test pamphlet San Diego; ACON Laboratories; 2010.
18. Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1991.
19. Deeks J, Altman D. Statistics Notes. Diagnostic tests 4: likelihood ratios. BMJ 2004; 329, 168-9.
20. Freeman M, Thom R. Serious mental illness and HIV/AIDS. S Afr J Psychiatry 2006; 12(1), 4-8.
21. Van Staden CW, Krüger C. Incapacity to give informed consent owing to mental disorder. J Med Ethics 2003; 29(1), 41-3.
22. Pavie J, Rachline A, Loze B, Niedbalskil L, Delauguerre C, Laforgerie E, et al. Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood, a real-time comparison in a healthcare setting. PLoS ONE 2010; 5(7), e11581.
23. Bartoloa R, Camachoc R, Barroso H, Bezerra V, Taveira N. Rapid clinical progression to AIDS and death in a persistently seronegative HIV-1 infected heterosexual young man. AIDS 2009; 23, 2359-70.
24. Spivak A, Sydnor E, Blankson J, Gallant J. Seronegative HIV-1 infection: a review of the literature. AIDS 2010; 24, 1407-14.
25. Zuger A. Rapid HIV testing is not without its flaws. AIDS Clin Care 2009; 21(1), 5.